Clinical Trial Update: Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing paricalcitol versus calcitriol for managing cardiorenal syndrome in renal transplant patients; the study completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allograft Nephropathy
• Cardiorenal Syndrome

Drugs mentioned

• Calcitriol (calcitriol)
• Paricalcitol (paricalcitol)

Snippet

Sponsor: Ural State Medical University | Conditions: Cardiorenal Syndrome, Chronic Allograft Nephropathy | Phase 4 | Status: COMPLETED | Results posted: 2011-06-21